Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1998 1
2001 2
2002 1
2004 1
2006 1
2007 3
2008 2
2009 4
2010 4
2011 2
2012 4
2013 1
2014 5
2015 6
2016 5
2017 9
2018 5
2019 9
2020 7
2021 5
2022 7
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Results by year
Filters applied: . Clear all
Page 1
Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial.
Lutsar I, Chazallon C, Trafojer U, de Cabre VM, Auriti C, Bertaina C, Calo Carducci FI, Canpolat FE, Esposito S, Fournier I, Hallik M, Heath PT, Ilmoja ML, Iosifidis E, Kuznetsova J, Meyer L, Metsvaht T, Mitsiakos G, Pana ZD, Mosca F, Pugni L, Roilides E, Rossi P, Sarafidis K, Sanchez L, Sharland M, Usonis V, Warris A, Aboulker JP, Giaquinto C; NeoMero Consortium. Lutsar I, et al. Among authors: sarafidis k. PLoS One. 2020 Mar 4;15(3):e0229380. doi: 10.1371/journal.pone.0229380. eCollection 2020. PLoS One. 2020. PMID: 32130261 Free PMC article. Clinical Trial.
Antimicrobial dosing in neonates.
Kontou A, Sarafidis K, Roilides E. Kontou A, et al. Among authors: sarafidis k. Expert Rev Clin Pharmacol. 2017 Mar;10(3):239-242. doi: 10.1080/17512433.2017.1279968. Epub 2017 Jan 27. Expert Rev Clin Pharmacol. 2017. PMID: 28067058 No abstract available.
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.
Hill LF, Clements MN, Turner MA, Donà D, Lutsar I, Jacqz-Aigrain E, Heath PT, Roilides E, Rawcliffe L, Alonso-Diaz C, Baraldi E, Dotta A, Ilmoja ML, Mahaveer A, Metsvaht T, Mitsiakos G, Papaevangelou V, Sarafidis K, Walker AS, Sharland M; NeoVanc Consortium. Hill LF, et al. Among authors: sarafidis k. Lancet Child Adolesc Health. 2022 Jan;6(1):49-59. doi: 10.1016/S2352-4642(21)00305-9. Epub 2021 Nov 26. Lancet Child Adolesc Health. 2022. PMID: 34843669 Clinical Trial.
Stüve-Wiedemann syndrome in a neonate.
Sarafidis K, Piretzi K, Agakidou E, Kohlhase J, Zafeiriou D. Sarafidis K, et al. Pediatr Int. 2015 Apr;57(2):302-4. doi: 10.1111/ped.12431. Pediatr Int. 2015. PMID: 25868946
72 results